Shanghai Kaibao Pharmaceutical Co., Ltd. logo

Shanghai Kaibao Pharmaceutical Co., Ltd. (300039)

Market Closed
10 Aug, 06:57
XSHE XSHE
¥
5. 84
-0.12
-2.0134%
¥
6.77B Market Cap
- P/E Ratio
0.12% Div Yield
79.36M Volume
- Eps
¥ 5.96
Previous Close
Add Transaction
Day Range
5.5 6
Year Range
4.02 7.02
Want to track 300039 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300039 closed yesterday lower at ¥5.84, a decrease of -2.0134% from Friday's close, completing a monthly increase of 38.0615% or ¥1.61. Over the past 12 months, 300039 stock lost -3.3113%.
300039 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 2 weeks on Aug 29, 2026 for a total of ¥0.1.
The last earnings report, released on Jun 05, 2025, exceeded the consensus estimates by 0.0806%. On average, the company has surpassed earnings expectations by 0.0678%, based on the last three reports.
Shanghai Kaibao Pharmaceutical Co., Ltd. has completed 6 stock splits, with the recent split occurring on May 10, 2017.
The company's stock is traded on one exchange.

300039 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Shanghai Kaibao Pharmaceutical Co., Ltd. (300039) FAQ

What is the stock price today?

The current price is ¥5.84.

On which exchange is it traded?

Shanghai Kaibao Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300039.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, the market cap is 6.77B.

Has Shanghai Kaibao Pharmaceutical Co., Ltd. ever had a stock split?

Shanghai Kaibao Pharmaceutical Co., Ltd. had 6 splits and the recent split was on May 10, 2017.

Shanghai Kaibao Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yingbin Zhou CEO
XSHE Exchange
CNE100000JZ3 ISIN
CN Country
1,225 Employees
29 May 2026 Last Dividend
10 May 2017 Last Split
8 Jan 2010 IPO Date

Overview

Shanghai Kaibao Pharmaceutical CO., Ltd is a leading entity in the realm of Chinese medicine, concentrating on the research, development, production, and commercialization of modern Chinese medical solutions. Founded in the year 2000 and headquartered in Shanghai, China, the company has established a robust presence in the Chinese healthcare market. Its commitment to innovation and quality has facilitated the provision of effective treatments for a variety of conditions, solidifying its status as a crucial player in the pharmaceutical industry within China.

Products and Services

Tanreqing Injection - This product is primarily used in the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. It reflects Shanghai Kaibao Pharmaceutical's expertise in creating solutions that target respiratory conditions effectively.

Tanreqing Capsules - Designed for clearing heat, detoxifying the body, and removing phlegm, these capsules represent the company's dedication to leveraging traditional Chinese medicine principles for modern healthcare needs.

Tiopronin for Injection - A testament to the company's commitment to liver health, this product aims at improving the liver function in patients suffering from various forms of acute and chronic hepatitis.

Tiopronin Enteric-coated Tablets - Serving as an adjuvant treatment for chronic hepatitis, these tablets highlight the company's focus on developing pharmaceuticals that support liver health and function.

Xiongdan Dropping Pills - This product is developed to clear heat, calm the liver, and improve eyesight, underscoring Shanghai Kaibao Pharmaceutical's utilization of traditional Chinese medicinal knowledge to address a broad spectrum of health concerns.

Contact Information

Address: No. 88 Chengpu Road, Shanghai, China, 201401
Phone: 86 21 3757 2030